Display options
Share it on

Open Heart. 2017 Mar 01;4(1):e000523. doi: 10.1136/openhrt-2016-000523. eCollection 2017.

Subclinical sleep apnoea and plasma levels of endothelin-1 among young and healthy adults.

Open heart

Tobias Schoen, Stefanie Aeschbacher, Joerg D Leuppi, David Miedinger, Ursina Werthmüller, Joel Estis, John Todd, Martin Risch, Lorenz Risch, David Conen

Affiliations

  1. Division of Cardiology, University Hospital Basel, Basel, Switzerland.
  2. Cardiovascular Research Institute Basel, Basel, Switzerland.
  3. Division of Internal Medicine, University Hospital Basel, Basel, Switzerland.
  4. Medical University Clinic of Baselland and Medical Faculty of Basel, Liestal/Basel, Switzerland.
  5. Faculty of Medicine, University of Basel, Basel, Switzerland.
  6. Singulex, Inc, Alameda, California, USA.
  7. Labormedizinisches Zentrum Dr. Risch, Schaan, Liechtenstein.
  8. Division of Laboratory Medicine, Kantonspital Graubünden, Chur, Switzerland.
  9. Division of Clinical Biochemistry, Medical University Innsbruck, Austria.
  10. Private University, Triesen, Liechtenstein.
  11. Cardiology Division, St. Joseph's Healthcare, Hamilton, Ontario, Canada.
  12. Population Health Research Institute, Vascular and Stroke Research Institute, Hamilton, Ontario, Canada.

PMID: 28409007 PMCID: PMC5384465 DOI: 10.1136/openhrt-2016-000523

Abstract

OBJECTIVE: Obstructive sleep apnoea (OSA) is a risk factor for vascular disease and other adverse outcomes. These associations may be at least partly due to early endothelin-1 (ET-1)-mediated endothelial dysfunction (ED). Therefore, we assessed the relationships between subclinical sleep apnoea and plasma levels of ET-1.

METHODS: We performed a population-based study among 1255 young and healthy adults aged 25-41 years. Cardiovascular disease, diabetes or a body mass index >35 kg/m

RESULTS: Median age of the cohort was 35 years. Median ET-1 levels were 2.9 (IQR 2.4-3.6) and 2.5 pg/mL (IQR 2.1-3.0) among patients with (n=105; 8%) and without subclinical sleep apnoea (REI 5-14), respectively. After multivariable adjustment, subclinical sleep apnoea remained significantly associated with plasma levels of ET-1 (β=0.13 (95% CI 0.06 to 0.20) p=0.0002 for a REI 5-14; β=0.10 (95% CI 0.03 to 0.16) p=0.003 for an ODI≥5). Every 1% decrease in mean night-time SpO

CONCLUSIONS: In this study of young and healthy adults, we found that participants with subclinical sleep apnoea had elevated plasma ET-1 levels, an association that was due to night-time hypoxaemia. Our results suggest that ED may already be an important consequence of subclinical sleep apnoea.

Keywords: ENDOTHELIN-1; HYPOXEMIA; SLEEP APNEA

Conflict of interest statement

Competing interests: JT and JE are employees of Singulex and hold stock options in Singulex. They are also co-inventors on patents filed in regard to assay methods for measuring endothelin-1 levels.

References

  1. J Cardiovasc Pharmacol. 2007 Dec;50(6):621-8 - PubMed
  2. BMJ Open. 2015 Jun 30;5(6):e007956 - PubMed
  3. Sleep. 1999 Aug 1;22(5):667-89 - PubMed
  4. Atherosclerosis. 2015 Mar;239(1):186-91 - PubMed
  5. Eur Heart J. 2013 Jul;34(28):2159-219 - PubMed
  6. Circulation. 2004 Oct 12;110(15):2233-40 - PubMed
  7. Am J Respir Crit Care Med. 2005 Dec 1;172(11):1447-51 - PubMed
  8. Arch Intern Med. 2000 Aug 14-28;160(15):2289-95 - PubMed
  9. Swiss Med Wkly. 2013 Jan 08;143:w13728 - PubMed
  10. Medicine (Baltimore). 2014 Dec;93(29):e336 - PubMed
  11. Chest. 2013 Sep;144(3):896-902 - PubMed
  12. J Physiol. 2009 Jul 1;587(Pt 13):3287-99 - PubMed
  13. J Clin Sleep Med. 2007 Jun 15;3(4):387-92 - PubMed
  14. J Clin Invest. 1991 Sep;88(3):1054-7 - PubMed
  15. Cardiovasc Res. 2007 Oct 1;76(1):8-18 - PubMed
  16. Metabolism. 2015 Sep;64(9):1103-11 - PubMed
  17. Am J Respir Crit Care Med. 2001 Jan;163(1):19-25 - PubMed
  18. J Clin Sleep Med. 2015 Nov 15;11(11):1253-4 - PubMed
  19. Diabetologia. 1999 Dec;42(12):1383-94 - PubMed
  20. Sleep. 2009 Apr;32(4):553-7 - PubMed
  21. Am J Respir Crit Care Med. 2008 Nov 1;178(9):984-8 - PubMed
  22. Exp Physiol. 2007 Jan;92 (1):51-65 - PubMed
  23. N Engl J Med. 2000 May 11;342(19):1378-84 - PubMed
  24. JAMA. 2000 Apr 12;283(14):1829-36 - PubMed
  25. Metabolism. 2008 Sep;57(9):1167-72 - PubMed
  26. N Engl J Med. 2005 Mar 24;352(12):1206-14 - PubMed
  27. Sleep. 2014 Nov 01;37(11):1817-24 - PubMed
  28. Cardiovasc J Afr. 2012 May;23(4):222-31 - PubMed
  29. J Am Coll Cardiol. 2013 Aug 13;62(7):610-6 - PubMed
  30. Circ J. 2015 ;79(6):1381-9 - PubMed
  31. Circulation. 2000 Nov 21;102(21):2607-10 - PubMed
  32. J Hypertens. 1999 Jan;17(1):61-6 - PubMed
  33. Chest. 2015 Jan;147(1):266-74 - PubMed
  34. Clin Chem. 2007 Nov;53(11):1990-5 - PubMed
  35. Arch Intern Med. 1997 Aug 11-25;157(15):1746-52 - PubMed
  36. Proc Jpn Acad Ser B Phys Biol Sci. 2006 Mar;82(1):17-24 - PubMed
  37. Circulation. 2015 Oct 6;132(14 ):1329-37 - PubMed
  38. BMJ. 2000 Feb 19;320(7233):479-82 - PubMed
  39. Adv Cardiol. 2011;46:139-70 - PubMed

Publication Types